个性化文献订阅>期刊> Current Pharmaceutical Design
 

Microbial Polysaccharides and their Derivatives as Current and Prospective Pharmaceuticals

  作者 Smelcerovic, A; Knezevic-Jugovic, Z; Petronijevic, Z  
  选自 期刊  Current Pharmaceutical Design;  卷期  2008年14-29;  页码  3168-3195  
  关联知识点  
 

[摘要]The ability to produce polysaccharides is widely found among microbial species. The structural diversity of the microbial polysaccharides (MPS) leads to a wide diversity of their applications. This review focuses pharmacological properties of MPS and their derivatives. They have been reported to possess many biological activities, such as antiviral, antitumor, antimicrobial and anticoagulant activities. So, the MPS of the type beta-1,3-D-glucans, including curdlan and scleroglucan, show antitumor and antiviral activity. A number of biological and synthetic sulfated polysaccharides, including sulfated polysaccharides from marine microalgae, inhibit viral infections. Many of MPS demonstrate a series of attractive properties as carrier materials in drug delivery systems and nonviral gene delivery. Furthermore, MPS have found an application as wound-healing agents, blood plasma expanders and vaccines. Some MPS, like chitin, chitosan and alginate have an unusual combination of biological activities and physicochemical properties leading to the development of novel or improved pharmaceuticals. They have become of a great interest not only as drug and cell carriers but also as new functional materials of high biological activity, and recent progress in MPS chemistry is quite noteworthy. This review also examines the advances in the application of MPS in the field of tissue engineering.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内